FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

18597911000001107: Risedronate sodium 35mg tablets (Actavis UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Apr 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63836901000001111 Risedronate sodium 35mg tablets (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63837001000001110 Risedronate sodium 35mg tablets (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risedronate sodium 35mg tablets (Actavis UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) Is a Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) Has active ingredient Risedronate sodium false Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) Has specific active ingredient Risedronate sodium true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Actavis UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Risedronate sodium 35mg tablets (Actavis UK Ltd) 4 tablet Has AMP True Risedronate sodium 35mg tablets (Actavis UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start